SUPRIYA Share Price Performance
₹772.75
69.30 (9.85%)
9.1% undervalued intrinsic discount
₹850.00
Fair Value
Price ₹772.75
AnalystConsensusTarget ₹850.00
Fair Value₹850.00
Share Pricen/a
Supriya Lifescience Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 15 Fair Values set on narratives written by author
SUPRIYA Community Narratives
AN
Fair Value ₹850 9.1% undervalued intrinsic discount
Backward Integration And India Sourcing Will Drive Resilient Manufacturing
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
Backward Integration And India Sourcing Will Drive Resilient Manufacturing
Key Takeaways Strategic backward integration and tech upgrades enhance operational resilience, margin sustainability, and earnings predictability amid global shifts in pharmaceutical ingredient sourcing. Focus on high-margin specialty APIs, portfolio expansion, and regulatory-compliant products strengthens market position and drives sustained revenue growth from regulated international markets.Read more
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
₹850
9.1% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
26.37% p.a.
Profit Margin
24.97%
Future PE
27.07x
Share price in 2028
₹1.21k
Recently Updated Narratives
AN
Backward Integration And India Sourcing Will Drive Resilient Manufacturing
Fair Value: ₹850 9.1% undervalued intrinsic discount
6 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Supriya Lifescience Limited Key Details
About SUPRIYA
- Founded
- 1987
- Employees
- 515
- CEO
- WebsiteView website
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
